Attached files

file filename
10-K - 10-K - UV FLU TECHNOLOGIES INCv330955_10k.htm
EX-32 - EXHIBIT 32 - UV FLU TECHNOLOGIES INCv330955_ex32.htm
EX-31.2 - EXHIBIT 31.2 - UV FLU TECHNOLOGIES INCv330955_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - UV FLU TECHNOLOGIES INCv330955_ex31-1.htm
EXCEL - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR4.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR2.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR8.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR1.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR5.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR7.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR9.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR3.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR6.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR21.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR37.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR18.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR33.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR38.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR11.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR29.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR19.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR26.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR17.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR30.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR28.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR27.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR34.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR14.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR13.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR31.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR35.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR36.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR23.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR32.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR25.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR16.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR15.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR24.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR20.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR10.htm
XML - IDEA: XBRL DOCUMENT - UV FLU TECHNOLOGIES INCR22.htm
v2.4.0.6
COMMON STOCK
12 Months Ended
Sep. 30, 2012
Stockholders' Equity Note [Abstract]  
COMMON STOCK
6. COMMON STOCK

 

Our authorized common stock consists of 75,000,000 shares of common stock with a par value of $0.001 per share. On January 20, 2012, the Company did a 1 for 4 reverse split of its common stock. All stock amount shown in these financial statements have been adjusted for that split.

 

On September 30, 2010, the Company had 11,270,000 shares of common stock issued and outstanding. There were no outstanding options or warrants.

 

On January 20, 2011, we issued 250,000 shares of common stock to the directors of the Company for compensation. The shares given were valued at the current market price of $.244 per share for a total consideration of $61,000

 

On February 9, 2011, we issued 375,000 shares of common stock in the acquisition of RxAir Industries, LLC. The shares issued were valued at the current market price on the date of acquisition of $135,000 ($.36 per share). See note10 for further details.

 

On February 9, 2011, we issued 56,250 shares of common stock to three key Rx Air personnel as for consulting services related to the acquisition of RxAir Industries, LLC. The shares given were valued at the current market price on the date of acquisition of $.36 per share for a total consideration of $20,250. See note 4

 

On February 22, 2011, we issued 437,500 shares of common stock to directors for compensation. The shares given were valued at the current market price of $.136 per share for a total consideration of $59,500.

 

On February 22, 2011, we issued 43,750 shares of common stock to consultants for consulting and marketing services to the Company. The shares given were valued at the current market price of $.136 per share for a total consideration of $5,950

 

On February 22, 2011, we issued 112,500 shares of common stock of the Company at a price of $0.08 for cash totaling $9,000

 

On February 25, 2011, we issued 2,486,549 shares of common stock at a price of $0.28 in settlement of $696,234 of convertible debt. See note 5 for further detail.

 

On May 2, 2011, we issued 537,500 shares of common stock at a price of $.08 for cash totaling $43,000.

 

On June 7, 2011, we issued 850,000 shares of common stock in the Company at a price of $.04 for cash totaling $34,000.

 

On June 7, 2011, we issued 550,000 shares of common stock as compensation for services performed. The shares were valued at the current market price of $.12 per share for a total consideration of $66,000.

 

On June 23, 2011, the Company approved a vote authorizing an increase in the number of shares authorized from 18.75 to 37.5 million shares.

 

On October 3, 2011, the Company approved a vote authorizing an increase in the number of shares authorized from 37.5 to 50 million shares. The Company also authorized a shareholder vote to approve the Company’s common stock to undergo a reverse stock split, on a ratio of 1:4. The reverse split was approved by shareholder vote and was officially done on January 20, 2012.

 

On September 30, 2011, the Company had 20,950,017 shares of common stock issued and outstanding. There were no outstanding options or warrants.

 

During the year ended September 30, 2012, the Company issued 10,845,834 shares of common stock in relation to conversions of notes payable in the amount of $266,300. See Note 5 for further details.

 

During the year ended September 30, 2012, the president of the Company contributed assets with a fair market value of $14,000 to the Company. This contribution will not be repaid and was considered contributed capital.

 

In October of 2011, the Company issued 4,291,667 shares for consulting services. The shares were valued at $0.24, fair market value, for a total expense of $103,000.

 

In October of 2011, the Company issued 1,729,167 shares of common stock for $55,500 of accounts payable held by a related party. The shares were valued at market value. See note 11 for further details.

 

In October of 2011, the Company issued 1,062,500 shares of common stock for compensation amounting to $25,500. The shares were valued at market value.

 

In December of 2011, the Company issued 62,500 shares of common stock at a purchase price of $.08, for total proceeds of $5,000.

 

In December of 2011, the Company issued 105,000 shares of common stock for consulting services. The shares were valued at $.06, fair market value, for a total expense of $6,300.

 

In February of 2012, the Company issued 493,750 shares of common stock at a purchase price of $.08, for total proceeds of $39,500.

 

In February of 2012, the Company issued 500,000 shares of common stock as compensation. The shares were valued at market value for a total expense of $90,000

 

In February of 2012, the Company issued 56,250 shares of common stock for consulting services. The shares were valued at $.08, fair market value, for a total expense of $4,500.

 

In February of 2012, the Company issued 400,000 to satisfy a $60,000 accrued expense liability. The shares were valued at fair market value.

 

In April of 2012, the Company issued 2,799,214 shares of common stock at a purchase price of $.04, for total proceeds of $121,162.

 

In April of 2012, the Company issued 600,000 shares of common stock as compensation. The shares were valued at market value for a total expense of $79,800

 

In April of 2012, the Company issued 100,000 shares of common stock for consulting services. The shares were valued at $.133, fair market value, for a total expense of $13,300.

 

In April of 2012, the Company issued 120,000 shares of common stock as payment of interest. The shares were valued at market value for a total expense of $7,200

 

In May of 2012, the Company issued 1,000,000 shares of common stock at a purchase price of $.05, for total proceeds of $50,000.

 

In May of 2012, the Company issued 113,333 shares of common stock for consulting services. The shares were valued at $.15, fair market value, for a total expense of $17,000.

 

In August and September of 2012, the Company issued 1,100,000 shares of common stock at various purchase prices, for total proceeds of $39,000.

 

In August and September of 2012, the Company issued 450,000 shares of common stock for consulting services. The shares were valued at fair market value, for a total expense of $25,500.

 

In September of 2012, the Company issued 100,000 shares of common stock as payment of interest. The shares were valued at market value for a total expense of $4,000

 

As of September 30, 2012, the Company has 46,859,263 shares of common stock issued and outstanding and no outstanding options or warrants.